NCT04191499 2026-03-17INAVO120Hoffmann-La RochePhase 2/3 Active not recruiting325 enrolled 14 charts 1 FDA
NCT04849364 2025-05-31PERSEVEREHoosier Cancer Research NetworkPhase 2 Terminated52 enrolled 16 charts